Synthetic bone grafts are primarily made of calcium-based ceramics, bioactive glass, or biodegradable polymers, all engineered to mimic the mineral composition of natural bone. The most common base material is calcium phosphate, which closely resembles the mineral your skeleton is already built from. These materials serve as a scaffold that your body gradually absorbs and replaces with real bone tissue.
Calcium Phosphate Ceramics
The backbone of most synthetic bone grafts is calcium phosphate, available in several forms. The two most widely used are hydroxyapatite and beta-tricalcium phosphate (β-TCP), both of which the FDA classifies as approved synthetic bone grafting materials.
Hydroxyapatite is the same mineral that makes up roughly 70% of natural bone. In graft form, it’s manufactured into a porous structure that acts as scaffolding for new bone cells to grow into. It resorbs slowly, sometimes taking years to fully break down. One study tracking hydroxyapatite-based grafts after sinus lift procedures found resorption rates of about 3.5% per month in the first two years, dropping to around 0.6% per month over the following eight years.
β-TCP dissolves faster than hydroxyapatite, which makes it useful when you want the graft to be replaced by natural bone on a shorter timeline. Many commercial products blend hydroxyapatite and β-TCP together in varying ratios, combining the structural durability of one with the faster resorption of the other. The exact proportions are adjusted depending on whether the graft needs to last months or years at the implant site.
Calcium Sulfate
Calcium sulfate, essentially medical-grade plaster of Paris, is one of the simplest and most affordable synthetic graft options. It resorbs quickly, averaging about 14.5 weeks in clinical use, with new bone filling in over roughly five to seven months. That fast turnover makes it a good fit for filling bone voids left after removing cysts or tumors, treating bone infections, or bridging fractures that haven’t healed.
The tradeoff is structural support. Calcium sulfate doesn’t bear weight on its own, so it typically needs metal plates, screws, or other fixation alongside it. The most common side effect is a watery discharge from the surgical site that isn’t caused by infection. It resolves on its own with basic wound care. Because it’s inexpensive and widely available, calcium sulfate is also frequently mixed with a patient’s own bone to stretch a limited supply of natural graft material further.
Bioactive Glass
Bioactive glass is a specially formulated glass that bonds directly to living bone. The original formulation, developed in the late 1960s, contains 45% silica, 24.5% sodium oxide, 24.5% calcium oxide, and 6% phosphorus pentoxide. When implanted, it reacts with body fluids to form a layer of calcium phosphate on its surface, which is what triggers bone cells to attach and begin building new tissue.
The category has expanded since then. Class A bioactive glasses, the most reactive type, generally contain 40 to 52% silica, 10 to 50% calcium oxide, and 10 to 35% sodium oxide. Adjusting these percentages changes how quickly the glass dissolves and how aggressively it stimulates bone growth. Bioactive glass is used in both orthopedic and dental applications, often as granules packed into a bone defect.
Biodegradable Polymers
Some synthetic grafts use biodegradable plastics instead of, or in addition to, ceramics. The most common polymers are polylactic acid, polyglycolic acid, a copolymer of the two called poly(lactic-co-glycolic acid), and polycaprolactone. These materials break down into byproducts your body can metabolize naturally, like lactic acid and carbon dioxide.
Polymers offer something ceramics can’t: flexibility in shaping. They can be molded, extruded, or 3D printed into complex geometries that match a specific defect. Polycaprolactone combined with hydroxyapatite is a common pairing in 3D-printed scaffolds because it mimics both the organic and mineral components of real bone. Polymethylmethacrylate (PMMA) is another option, though it doesn’t degrade. It’s used as a permanent filler, most often in spinal applications.
Why Pore Size Matters
Regardless of the base material, the physical structure of a synthetic graft is just as important as its chemistry. These grafts are manufactured with tiny pores that allow bone cells, blood vessels, and oxygen to move through the scaffold. Most effective grafts have pores larger than 100 micrometers in diameter. Below that threshold, cells can’t migrate through the material properly, and tissue at the center of the graft can die from lack of oxygen.
Larger pores, above 300 micrometers, encourage more cell migration overall, but going too large reduces the surface area cells can grab onto and weakens the scaffold mechanically. Research suggests the relationship is more nuanced than a single ideal number. One study of polymer scaffolds found that pores of 350 and 800 micrometers played a surprisingly limited role in bone regeneration, pointing to factors like how well pores connect to each other as potentially more important than size alone.
How Synthetic Grafts Compare to Natural Bone Grafts
The traditional gold standard in bone grafting is autograft, bone harvested from another site on your own body, typically the hip. Autografts contain living bone cells and natural growth factors, which is why they’ve long been considered the benchmark. But they require a second surgical site, add pain and recovery time, and supply is limited.
Synthetic grafts have been closing the performance gap. In a recent spinal fusion study, a novel synthetic graft achieved approximately 80% fusion rates compared to about 50% for bone autograft. The difference was even more dramatic among smokers, a group notoriously prone to failed fusions: roughly 75% fusion with the synthetic graft versus about 30% with autograft. These results suggest that the best synthetic options are no longer just acceptable alternatives but competitive performers in their own right.
Compression strength tells a similar story. In animal studies of synthetic grafts used to fill femoral defects, the graft site reached the compressive strength of intact bone (about 3.2 megapascals) by eight weeks. By twelve weeks, it exceeded intact bone strength, reaching approximately 5.2 megapascals when combined with platelet-rich fibrin.
3D-Printed and Composite Scaffolds
The newest generation of synthetic grafts blends multiple materials into composite scaffolds, often built using 3D printing. A printer can layer polycaprolactone with hydroxyapatite nanoparticles to create a structure that mirrors the density and porosity of the exact bone it’s replacing. Some composites incorporate graphene oxide to boost mechanical strength to levels comparable to trabecular bone, the spongy bone found inside vertebrae and at the ends of long bones.
These scaffolds can also be loaded with bioactive compounds. Some carry molecules that promote blood vessel formation, solving one of the biggest challenges in bone repair: getting a blood supply established deep inside a large graft. Others include antibacterial agents to reduce infection risk. Magnetic hydrogels, bio-ceramic composites, and scaffolds that release medications over days or weeks are all in active clinical development, expanding what synthetic grafts can do beyond simple gap-filling into true biological engineering.